Find Mitomycin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

0INTERMEDIATES

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

JP

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

30 RELATED EXCIPIENT COMPANIES

61EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Mitomycin, 50-07-7, Ametycine, Mutamycin, Mitomycin-c, Mitocin-c
Molecular Formula
C15H18N4O5
Molecular Weight
334.33  g/mol
InChI Key
NWIBSHFKIJFRCO-WUDYKRTCSA-N
FDA UNII
50SG953SK6

Mitomycin
An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
Mitomycin is an Alkylating Drug. The mechanism of action of mitomycin is as an Alkylating Activity.
1 2D Structure

Mitomycin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate
2.1.2 InChI
InChI=1S/C15H18N4O5/c1-5-9(16)12(21)8-6(4-24-14(17)22)15(23-2)13-7(18-13)3-19(15)10(8)11(5)20/h6-7,13,18H,3-4,16H2,1-2H3,(H2,17,22)/t6-,7+,13+,15-/m1/s1
2.1.3 InChI Key
NWIBSHFKIJFRCO-WUDYKRTCSA-N
2.1.4 Canonical SMILES
CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
2.1.5 Isomeric SMILES
CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N
2.2 Other Identifiers
2.2.1 UNII
50SG953SK6
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ametycine

2. Mitocin C

3. Mitocin-c

4. Mitocinc

5. Mitomycin

6. Mitomycin-c

7. Mutamycin

8. Nsc 26980

9. Nsc-26980

10. Nsc26980

2.3.2 Depositor-Supplied Synonyms

1. Mitomycin

2. 50-07-7

3. Ametycine

4. Mutamycin

5. Mitomycin-c

6. Mitocin-c

7. Mytozytrex

8. Ametycin

9. Mitomycinum

10. Mytomycin

11. Mitozytrex

12. Mitamycin

13. Mitosol

14. Mmc

15. Nsc-26980

16. Muamycin

17. 7-amino-9alpha-methoxymitosane

18. C15h18n4o5

19. Nsc 26980

20. Mitomycyna C

21. Nci-c04706

22. Mito-c

23. Nsc26980

24. Mit-c

25. Mitomycinum C

26. Mitocin C

27. Chebi:27504

28. Rcra Waste Number U010

29. Ugn-101

30. Ugn-102

31. 50sg953sk6

32. Mitomycyna C [polish]

33. 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione Carbamate (ester)

34. Dsstox_cid_898

35. Dsstox_rid_75853

36. Dsstox_gsid_20898

37. Mitomycin (tn)

38. [(1as,8s,8ar,8bs)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl Carbamate

39. [(4s,6s,7r,8s)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0^{2,7}.0^{4,6}]trideca-1(9),11-dien-8-yl]methyl Carbamate

40. Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1as,8s,8ar,8bs)-

41. Cas-50-07-7

42. Muamycin (tn)

43. ((1as,8s,8ar,8bs)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2',3':3,4]pyrrolo[1,2-a]indol-8-yl)methyl Carbamate

44. [1as-(1a?,8?,8a?,8b?)]-6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione

45. Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1as,8s,8ar,8bs)-

46. Ccris 414

47. Hsdb 3239

48. Mitomycin (usp/inn)

49. Mls002702984

50. (amino-methoxy-methyl-dioxo-[?]yl)methyl Carbamate

51. Einecs 200-008-6

52. Rcra Waste No. U010

53. 7-amino-9.alpha.-methoxymitosane

54. Mitonco

55. Mitoplus

56. Mitoextra

57. Unii-50sg953sk6

58. Ai3-26199

59. Mitomycin [usan:usp:inn:ban]

60. Ncgc00095258-01

61. [(1as,8s,8ar,8bs)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2'',3'':3,4]pyrrolo[1,2-a]indol-8-yl]methyl Carbamate

62. [(1as,8s,8ar,8bs)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl Carbamate

63. Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methyl-, Carbamate (ester)

64. Jelmyto (tn)

65. Mfcd00078109

66. Jelmyto

67. Mitomycin C- Bio-x

68. Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1as-(1aalpha,8beta,8aalpha,8balpha))-

69. Mitomycin C From Streptomyces Caespitosus

70. Mitomycin [inn]

71. Mitomycin C (jp17)

72. Mitomycin [hsdb]

73. Mitomycin [usan]

74. Mitomycin [vandf]

75. Mitomycin C [mi]

76. Chembl105

77. Mitomycin [mart.]

78. Mitomycin C [jan]

79. Mitomycin [usp-rs]

80. Mitomycin [who-dd]

81. Mitomycin C [iarc]

82. Schembl3760

83. Cbiol_001927

84. Bspbio_001267

85. Kbiogr_000607

86. Kbioss_000607

87. Mitomycin C (4% In Nacl)

88. Mls001332654

89. Mitozytrex (tn) (supergene)

90. 50-07-7 (non-salt)

91. Ametycin Pound Notmitomycin C

92. Gtpl7089

93. Mitomycin [orange Book]

94. Dtxsid2020898

95. Mitomycin [ep Monograph]

96. Kbio2_000607

97. Kbio2_003175

98. Kbio2_005743

99. Kbio3_001073

100. Kbio3_001074

101. Ex-a501

102. Mitomycin [usp Monograph]

103. Bcpp000410

104. Bio1_000213

105. Bio1_000702

106. Bio1_001191

107. Bio2_000464

108. Bio2_000944

109. Hms1362o09

110. Hms1792o09

111. Hms1990o09

112. Hms2089f16

113. Hms3403o09

114. Amy10316

115. Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1as-(1a.alpha.,8.beta.,8a.alpha.,8b.alpha.))-

116. Tox21_111493

117. Ac-918

118. Bdbm50428658

119. Gr-311

120. S8146

121. Zinc30726187

122. Akos015895703

123. Tox21_111493_1

124. Bcp9000285

125. Ccg-208564

126. Cs-0564

127. Db00305

128. Ks-5148

129. Idi1_002219

130. Smp1_000307

131. Mitomycin 100 Microg/ml In Acetonitrile

132. Ncgc00163468-02

133. Ncgc00163468-03

134. Ncgc00163468-05

135. Ncgc00163468-06

136. 1404-00-8

137. Bm164668

138. Hy-13316

139. Smr000058401

140. Bcp0726000181

141. M2320

142. C06681

143. D00208

144. D91590

145. Ab00918689-03

146. Ab00918689-04

147. 078m109

148. Mitomycin C, Antibiotic For Culture Media Use Only

149. Q-201410

150. Brd-k59670716-001-02-6

151. Brd-k59670716-001-06-7

152. Q19856779

153. Wln: T D3 B556 Bn Em Jv Mvttt&j Go1 H1ovz Kz L1

154. Mitomycin C From Streptomyces Caespitosus, >=970 Mug/mg (usp Xxiv)

155. Mitomycin C From Streptomyces Caespitosus, Powder, Bioreagent, Suitable For Cell Culture

156. Mitomycin C From Streptomyces Caespitosus, Powder, Contains Nacl As Solubilizer

157. Azirino[2',4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a- Methoxy-5-methyl-, Carbamate (ester)

158. Azirino[2',4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b- Hexahydro-8a-methoxy-5-methyl-, [1ar-(1a.alpha.,8.beta.,8a.alpha.,8b.alpha.)]-

159. Mitomycin C From Streptomyces Caespitosus, >=98% (hplc), Potency: >=970 Mug Per Mg (usp Xxiv), Gamma-irradiated, Suitable For Cell Culture

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 334.33 g/mol
Molecular Formula C15H18N4O5
XLogP3-0.4
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count8
Rotatable Bond Count4
Exact Mass334.12771969 g/mol
Monoisotopic Mass334.12771969 g/mol
Topological Polar Surface Area147 Ų
Heavy Atom Count24
Formal Charge0
Complexity757
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameMitomycin
PubMed HealthMitomycin
Drug ClassesAntibiotic, Antineoplastic Agent
Drug LabelMitomycin (also known as mitomycin and/or mitomycin-C) is an antibiotic isolated from the broth of Streptomyces caespitosus which has been shown to have antitumor activity. The compound is heat stable, has a high melting point, and is freely soluble...
Active IngredientMitomycin
Dosage FormInjectable
RouteInjection
Strength5mg/vial; 20mg/vial; 40mg/vial
Market StatusPrescription
CompanyBedford; Accord Hlthcare; Hikma Maple

2 of 4  
Drug NameMitosol
Active IngredientMitomycin
Dosage FormFor solution
RouteTopical
Strength0.2mg/vial
Market StatusPrescription
CompanyMobius Therap

3 of 4  
Drug NameMitomycin
PubMed HealthMitomycin
Drug ClassesAntibiotic, Antineoplastic Agent
Drug LabelMitomycin (also known as mitomycin and/or mitomycin-C) is an antibiotic isolated from the broth of Streptomyces caespitosus which has been shown to have antitumor activity. The compound is heat stable, has a high melting point, and is freely soluble...
Active IngredientMitomycin
Dosage FormInjectable
RouteInjection
Strength5mg/vial; 20mg/vial; 40mg/vial
Market StatusPrescription
CompanyBedford; Accord Hlthcare; Hikma Maple

4 of 4  
Drug NameMitosol
Active IngredientMitomycin
Dosage FormFor solution
RouteTopical
Strength0.2mg/vial
Market StatusPrescription
CompanyMobius Therap

4.2 Therapeutic Uses

Antibiotics, Antineoplastic; Nucleic Acid Synthesis Inhibitors

National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)


Mitomycin is useful for the palliative treatment of gastric adenocarcinoma, in conjunction with fluorouracil and doxorubicin. It has produced temporary beneficial effects in carcinomas of the cervix, colon, rectum, pancreas, breast, bladder, head and neck, and lung, and in melanoma. It has also shown activity against lymphomas and leukemia, particularly chronic granulocytic leukemia, but not in myeloma.

Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1247


Thirty patients with advanced colorectal adenocarcinoma were treated by chemotherapy with an alternating regimen consisting of 5-fluorouracil mitomycin C and 5-fluorouracil dacarbazine at 3 wk intervals. ... The toxicity of this regimen was essentially digestive with 30% of grade 3 or 4 nausea and vomiting. In spite of the reported active and synergistic action of drug association in colorectal carcinoma, this treatment schedule is not better than 5-fluorouracil alone. Gastrointestinal toxicity was incr.

PMID:2496369 Herait P et al; Oncology 46 (2): 88-90 (1989)


Forty-two patients with metastatic breast cancer refractory to first line therapies were treated with combination chemotherapy with mitomycin-C and vinblastine. ... The toxicity was acceptable with 20 episodes of moderate myelosuppression (58.8%) and 2 cases with congestive heart failure that responded to medical treatment.

PMID:2497417 Navarro M et al; Oncology 46 (3): 137-42 (1989)


For more Therapeutic Uses (Complete) data for MITOMYCIN C (19 total), please visit the HSDB record page.


4.3 Drug Warning

Mitomycin is contraindicated in patients with pre-existing myelosupression & anemia.

Knoben, J.E. and P.O. Anderson (eds.) Handbook of Clinical Drug Data. 6th ed. Bethesda, MD: Drug Intelligence Publications, Inc. 1988., p. 417


Because normal defense mechanisms may be suppressed by mitomycin therapy, the patient's antibody response to the vaccine may be decreased. The interval between discontinuation of medications that cause immunosuppression and restoration of the patient's ability to respond to the vaccine depends on the intensity and type of immunosuppression-causing medication used, the underlying disease, and other factors; estimates vary from 3 months to 1 year.

USP Convention. USPDI - Drug Information for the Health Care Professional. 16th ed. Volume I. Rockville, MD: U.S. Pharmaceutical Convention, Inc. 1996 (Plus updates)., p. 2088


cBecause normal defense mechanisms may be suppressed by mitomycin therapy, concurrent use with a live virus vaccine may potentiate the replication of the vaccine virus, may increase the side/adverse effects of the vaccine virus, and/or may decrease the patient's antibody response to the vaccine; immunization of these patients should be undertaken only with extreme caution after careful review of the patient's hematologic status and only with the knowledge and consent of the physician managing the cytarabine therapy. The interval between discontinuation of medication that cause immunosuppression and restoration of the patient's ability to respond to the vaccine depends on the intensity and type of immunosuppression-causing medications used, the underlying disease, and other factors; estimates vary from 3 months to 1 year. Patients with leukemia in remission should not receive live virus vaccine until at least 3 months after their last chemotherapy. In addition, immunization with oral polio-virus vaccine should be postponed in persons in close contact with the patient, especially family members.

USP Convention. USPDI - Drug Information for the Health Care Professional. 16th ed. Volume I. Rockville, MD: U.S. Pharmaceutical Convention, Inc. 1996 (Plus updates)., p. 2088


Gonadal suppression, resulting in amenorrhea or azoospermia, may occur in patients taking antineoplastic therapy, especially with the alkylating agents. In general, these effects appear to be related to dose and length of therapy and may be irreversible. Prediction of the degree of testicular or ovarian function impairment is complicated by the common use of combinations of several antineoplastics, which makes it difficult to assess the effects of individual agents.

USP Convention. USPDI - Drug Information for the Health Care Professional. 16th ed. Volume I. Rockville, MD: U.S. Pharmaceutical Convention, Inc. 1996 (Plus updates)., p. 2087


For more Drug Warnings (Complete) data for MITOMYCIN C (6 total), please visit the HSDB record page.


4.4 Drug Indication

For treatment of malignant neoplasm of lip, oral cavity, pharynx, digestive organs, peritoneum, female breast, and urinary bladder. Also used as an adjunct to ab externo glaucoma surgery. Mitomycin is also indicated as a pyelocalyceal solution for the treatment of adults with low-grade upper tract urothelial cancer (LG-UTUC).


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Mitomycin is one of the older chemotherapy drugs, which has been around and in use for decades. It is an antibiotic which has been shown to have antitumor activity. Mitomycin selectively inhibits the synthesis of deoxyribonucleic acid (DNA). The guanine and cytosine content correlates with the degree of mitomycin-induced cross-linking. At high concentrations of the drug, cellular RNA and protein synthesis are also suppressed. Mitomycin has been shown in vitro to inhibit B cell, T cell, and macrophage proliferation and impair antigen presentation, as well as the secretion of interferon gamma, TNFa, and IL-2.


5.2 MeSH Pharmacological Classification

Alkylating Agents

Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)


Antibiotics, Antineoplastic

Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)


Nucleic Acid Synthesis Inhibitors

Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)


Cross-Linking Reagents

Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
MITOMYCIN
5.3.2 FDA UNII
50SG953SK6
5.3.3 Pharmacological Classes
Alkylating Drug [EPC]; Alkylating Activity [MoA]
5.4 ATC Code

L - Antineoplastic and immunomodulating agents

L01 - Antineoplastic agents

L01D - Cytotoxic antibiotics and related substances

L01DC - Other cytotoxic antibiotics

L01DC03 - Mitomycin


5.5 Absorption, Distribution and Excretion

Absorption

Erratic.


Route of Elimination

Approximately 10% of a dose of mitomycin is excreted unchanged in the urine.


FOLLOWING IV INJECTION OF 2 MG/KG BODY WT ... WISTAR RATS, 18% WAS RECOVERED UNCHANGED IN URINE WITHIN 24 HR AT ... 8 MG/KG ... 35% WAS RECOVERED IN URINE, BUT NONE IN FECES OR TISSUES.

IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V10 174 (1976)


THIRTY MIN AFTER IV INJECTION OF 8 MG/KG BODY WT TO MICE TRACES REMAINED IN BLOOD. IN GUINEA PIGS DRUG WAS CONCN IN KIDNEYS & NOT IN LIVER, SPLEEN OR BRAIN & WAS EXCRETED IN URINE.

IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V10 174 (1976)


Mitomycin is absorbed inconsistently from the gastrointestinal tract, and it is therefore administered intravenously. It disappears rapidly from the blood after injection. Peak concentrations in plasma are 0.4 ug/ml after doses of 20 mg/m sq ... The drug is widely distributed throughout the body but is not detected in the brain.

Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1247


In animals, highest mitomycin concentrations are found in the kidneys, followed by muscles, eyes, lung, intestines, and stomach. The drug is not detectable in the liver, spleen, or brain which rapidly inactivate mitomycin. Higher concentrations of the drug are generally present in cancer tissues than in normal tissues.

McEvoy, G.K. (ed.). AHFS Drug Information 90. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1990 (Plus Supplements 1990)., p. 537


For more Absorption, Distribution and Excretion (Complete) data for MITOMYCIN C (9 total), please visit the HSDB record page.


5.6 Metabolism/Metabolites

Primarily hepatic, some in various other tissues.


SUGGESTED ALKYLATING METABOLITES OF CARCINOGENS: MITOMYCIN C: REDUCTION PRODUCTS. /FROM TABLE/

Searle, C. E. (ed.). Chemical Carcinogens. ACS Monograph 173. Washington, DC: American Chemical Society, 1976., p. 95


Inactivation occurs by metabolism, but the products have not been identified. It is metabolized primarily in the liver, and less than 10% of the active drug is excreted in the urine or the bile.

Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1247


The drug is eliminated primarily by hepatic metabolism with about 20% hepatic extraction and 10-30% recovery of intact drug in the urine. Clearance is 0.3-0.4 l/hr/kg.

IATA. Dangerous Goods Regulations. 30th ed. Montreal, Canada: International Air Transport Association. Dangerous Goods Board, January 1, 1989., p. 416


Mitomycin disappears rapidly from the blood after intravenous injection. It is widely distributed but does not appear to cross the blood-brain barrier. Mitomycin is metabolized mainly in the liver; up to 10% of a dose is excreted unchanged in the urine.

Reynolds, J.E.F., Prasad, A.B. (eds.) Martindale-The Extra Pharmacopoeia. 28th ed. London: The Pharmaceutical Press, 1982., p. 221


MITOMYCIN C WAS PREFERENTIALLY ACTIVATED & METABOLIZED BY SONICATED CELL PREPARATIONS. BIOACTIVATION OF MITOMYCIN TO ALKYLATING AGENT BY EMT6 & SARCOMA 180 CELL SONICATES REQUIRED HYPOXIC CONDITIONS & NADPH-GENERATING SYSTEM.

PMID:7388797 KENNEDY KA ET AL; CANCER RES 40 (7): 2356 (1980)


5.7 Biological Half-Life

8-48 min


After doses of 20 mg/m sq ... Mitomycin is cleared from plasma with a half-time of approximately 1 hour.

Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1247


/Mitomycin/ has an alpha half-life of 5-10 min after IV injection and beta half-life of 46 min.

Knoben, J.E. and P.O. Anderson (eds.) Handbook of Clinical Drug Data. 6th ed. Bethesda, MD: Drug Intelligence Publications, Inc. 1988., p. 416


5.8 Mechanism of Action

Mitomycin is activated in vivo to a bifunctional and trifunctional alkylating agent. Binding to DNA leads to cross-linking and inhibition of DNA synthesis and function. Mitomycin is cell cycle phase-nonspecific.


... REACTS WITH BACTERIAL DNA BUT NOT WITH ISOLATED DNA, UNLESS ... REDUCING SYSTEM IS ADDED. CROSS LINKING EFFICIENCY ... INCR IN ISOLATED BACTERIAL DNA CONTAINING INCR AMT OF CYTOSINE & GUANOSINE.

IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V10 175 (1976)


ITS REDUCED FORM CONTAINS INDOLE GROUP EMBODYING ALLYLIC CARBAMATE RESIDUE. ANTIBIOTIC IS CYTOTOXIC & CARCINOGENIC BUT IS INACTIVE AS CYTOTOXIC AGENT UNLESS REDUCED ... IT ACTS AS DIFUNCTIONAL AGENT IN CROSS LINKING DNA.

Searle, C. E. (ed.). Chemical Carcinogens. ACS Monograph 173. Washington, DC: American Chemical Society, 1976., p. 96


The drug inhibits DNA synthesis and cross-links DNA at the N6 position of adenine and at the O6 and N2 positions of guanine. In addition, single-strand breakage of DNA is caused by reduced mitomycin; this can be prevented by free radical scavengers. Its action is most prominent during the late G1 and early S phases of the cell cycle.

Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1247


In high concentrations ... /mitomycin/ may ... inhibit RNA and protein synthesis.

McEvoy, G.K. (ed.). AHFS Drug Information 90. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1990 (Plus Supplements 1990)., p. 537


For more Mechanism of Action (Complete) data for MITOMYCIN C (11 total), please visit the HSDB record page.


API SUPPLIERS

read-more
read-more

01

ChemWerth Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Chemwerth Compnay Banner

02

Shanghai Minbiotech

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Shanghai Minbiotech CB

03

TAPI Technology & API Services

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI offers customized CDMO Solutions for API development and manufacturing services.

Flag Israel
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF CA, ASMF arrow-down AUDIT
TAPI Company Banner

04

Concord Biotech

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

Concord Biotech

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WCInactive-api NDC arrow-down KDMF VMF Others AUDIT
blank

05

Hubei Honch Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

Hubei Honch Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

06

Wuxi Fortune Pharmaceutical Co., L...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

Wuxi Fortune Pharmaceutical Co., L...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

07

Zhejiang Hisun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

Zhejiang Hisun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
USDMF arrow-down CEP/COS Inactive-api JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

08

Kyowa Hakko Bio

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

Kyowa Hakko Bio

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Country

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Zhejiang Hisun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

Zhejiang Hisun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
USDMF Inactive-api CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 33811

Submission : 2019-11-04

Status : Active

Type : II

Chemwerth Compnay Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI offers customized CDMO Solutions for API development and manufacturing services.

Flag Israel
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2012-11-29

Pay. Date : 2012-11-09

DMF Number : 13791

Submission : 1998-09-01

Status : Active

Type : II

TAPI Company Banner

03

Concord Biotech Ltd

India

USDMF

arrow
Antibody Engineering
Not Confirmed

03

Antibody Engineering
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2019-10-21

Pay. Date : 2019-04-24

DMF Number : 33662

Submission : 2019-04-20

Status : Active

Type : II

blank

04

Antibody Engineering
Not Confirmed

05

Antibody Engineering
Not Confirmed

05

Antibody Engineering
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 13521

Submission : 1998-09-01

Status : Inactive

Type : II

blank

06

Antibody Engineering
Not Confirmed

06

Antibody Engineering
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2021-03-23

Pay. Date : 2020-09-25

DMF Number : 34866

Submission : 2020-09-14

Status : Active

Type : II

blank

07

Antibody Engineering
Not Confirmed

07

Antibody Engineering
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2013-10-08

Pay. Date : 2012-11-15

DMF Number : 25659

Submission : 2011-12-30

Status : Active

Type : II

blank

08

Antibody Engineering
Not Confirmed

08

Antibody Engineering
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 13783

Submission : 1998-09-01

Status : Inactive

Type : II

blank

09

Biological Therapy Institute

Country

USDMF

arrow
Antibody Engineering
Not Confirmed

09

Biological Therapy Institute

Country
arrow
Antibody Engineering
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 18599

Submission : 1988-07-14

Status : Inactive

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-more

01

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

Mitomycin EP/USP

Date of Issue : 2019-09-23

Valid Till : 2022-07-02

Written Confirmation Number : WC-0111

Address of the Firm : Plot No. 1482-1486, Trasad Road, Dholka, Dist- Ahmedabad 

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1622485800,"product":"MITOMYCIN USP (BATCH NO.49420003 MFG DT : OCT 2020 RETEST DT: SEP 2023)","address":"302, SAKAR - III, NR. OLD HIGHCOURTOFF. INCOME TAX OFFICE,","city":"AHMEDABAD ,GUJARAT","supplier":"CONCORD BIOTECH","supplierCountry":"INDIA","foreign_port":"CINCINNATI OH","customer":"TO ORDER,","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.002","unit":"KGS","unitRateFc":"318822","totalValueFC":"624.7","currency":"USD","unitRateINR":22971125,"date":"01-Jun-2021","totalValueINR":"45942.25","totalValueInUsd":"624.7","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"2140224","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"302, SAKAR - III, NR. OLD HIGHCOURTOFF. INCOME TAX OFFICE,, AHMEDABAD ,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1627237800,"product":"MITOMYCIN PH.EUR (BATCH NO. 49421005, MF","address":"302, SAKAR - III, NR. OLD HIGHCOURTOFF. INCOME TAX OFFICE,","city":"AHMEDABAD ,GUJARAT","supplier":"CONCORD BIOTECH","supplierCountry":"INDIA","foreign_port":"MUNICH","customer":"FLAVINE","customerCountry":"GERMANY","quantity":"0.01","actualQuantity":"0.005","unit":"KGS","unitRateFc":"247000","totalValueFC":"1207.6","currency":"EUR","unitRateINR":18000000,"date":"26-Jul-2021","totalValueINR":"90000","totalValueInUsd":"1207.6","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"3391109","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"302, SAKAR - III, NR. OLD HIGHCOURTOFF. INCOME TAX OFFICE,, AHMEDABAD ,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640802600,"product":"MITOMYCIN USP (BATCH NO: 49421013 & 4942","address":"1482 1486 TRASAD ROAD,DHOLKA","city":"AHMEDABAD,GUJARAT","supplier":"CONCORD BIOTECH","supplierCountry":"INDIA","foreign_port":"MONTREAL-DORAVAL APT","customer":"MEDISCA INC","customerCountry":"CANADA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"350000","totalValueFC":"104751.5","currency":"USD","unitRateINR":26336666.666666668,"date":"30-Dec-2021","totalValueINR":"7901000","totalValueInUsd":"104751.5","indian_port":"AHMEDABAD AIR","hs_no":"29420090","bill_no":"7127822","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"1482 1486 TRASAD ROAD,DHOLKA, AHMEDABAD,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655404200,"product":"MITOMYCIN EP (BATCH NO.49421005) (MFG.DT","address":"1482 1486 TRASAD ROAD,DHOLKA","city":"AHMEDABAD,GUJARAT","supplier":"CONCORD BIOTECH","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"BIOPHARM INTERNATIONAL CO. ","customerCountry":"TAIWAN","quantity":"0.01","actualQuantity":"0.005","unit":"KGS","unitRateFc":"320000","totalValueFC":"1256.2","currency":"USD","unitRateINR":19600000,"date":"17-Jun-2022","totalValueINR":"98000","totalValueInUsd":"1256.2","indian_port":"AHMEDABAD AIR","hs_no":"29420090","bill_no":"2199101","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"1482 1486 TRASAD ROAD,DHOLKA, AHMEDABAD,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1657045800,"product":"MITOMYCIN USP BCH NO.49421010 & 11 MFG D","address":"1482 1486 TRASAD ROAD,DHOLKA","city":"AHMEDABAD,GUJARAT","supplier":"CONCORD BIOTECH","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"KINDOS PHARMACEUTICALS CO. ","customerCountry":"CHINA","quantity":"0.56","actualQuantity":"0.556","unit":"KGS","unitRateFc":"350000","totalValueFC":"188124.4","currency":"USD","unitRateINR":26904676.258992802,"date":"06-Jul-2022","totalValueINR":"14959000","totalValueInUsd":"188124.4","indian_port":"AHMEDABAD AIR","hs_no":"29420090","bill_no":"2638249","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"1482 1486 TRASAD ROAD,DHOLKA, AHMEDABAD,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1692642600,"product":"MITOMYCIN USP BATCH NO. 1949A423009 MANUFACTURING","address":"D 1482 1486 TRASAD ROADDHOLKA","city":"AHMEDABAD","supplier":"CONCORD BIOTECH","supplierCountry":"INDIA","foreign_port":"CHENGDU","customer":"Z TO ORDER AND NA","customerCountry":"CHINA","quantity":"0.18","actualQuantity":"0.18","unit":"KGS","unitRateFc":"325000","totalValueFC":"57745.4","currency":"USD","unitRateINR":26574520.199999999,"date":"22-Aug-2023","totalValueINR":"4783413.636","totalValueInUsd":"57745.4","indian_port":"AHMEDABAD AIR","hs_no":"29420090","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"D 1482 1486 TRASAD ROADDHOLKA, AHMEDABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1693765800,"product":"MITOMYCIN USP (BATCH NO 1949A423011 MFG.DATE. AUG 2023 RETEST DT.JULY 2026)","address":"1482-1486, TRASAD ROAD,","city":"AHMEDABAD ,GUJARAT","supplier":"CONCORD BIOTECH","supplierCountry":"INDIA","foreign_port":"CHENGDU","customer":"TO ORDER,","customerCountry":"CHINA","quantity":"0.20","actualQuantity":"0.195","unit":"KGS","unitRateFc":"325000","totalValueFC":"62560.1","currency":"USD","unitRateINR":26630769.230769228,"date":"04-Sep-2023","totalValueINR":"5193000","totalValueInUsd":"62560.1","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"3688280","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"1482-1486, TRASAD ROAD,, AHMEDABAD ,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696962600,"product":"MITOMYCIN USP(ALONG WITH WS MITOMYCIN -1.70 GM)(BATCH NO.1949A423013 MFG. DATE.SEP 2023 RETEST DT. AUG 2026)","address":"1482-1486, TRASAD ROAD,","city":"AHMEDABAD ,GUJARAT","supplier":"CONCORD BIOTECH","supplierCountry":"INDIA","foreign_port":"CHENGDU","customer":"TO ORDER,","customerCountry":"CHINA","quantity":"0.12","actualQuantity":"0.115","unit":"KGS","unitRateFc":"325000","totalValueFC":"36910.1","currency":"USD","unitRateINR":26713043.478260867,"date":"11-Oct-2023","totalValueINR":"3072000","totalValueInUsd":"36910.1","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"4546674","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"1482-1486, TRASAD ROAD,, AHMEDABAD ,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710181800,"product":"MITOMYCIN PH.EUR. (SICOR TEVA) (JDMF)","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"INTAS PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"NARITA APT\/TOKYO","customer":"KYOWA KIRIN","customerCountry":"JAPAN","quantity":"0.03","actualQuantity":"30","unit":"GMS","unitRateFc":"1276.1","totalValueFC":"37804.4","currency":"USD","unitRateINR":104637.33333333333,"date":"12-Mar-2024","totalValueINR":"3139120","totalValueInUsd":"37804.4","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29419090","bill_no":"4001488","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad-ZIPL-SEZ","supplierAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,, AHMEDABAD,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710959400,"product":"MITOMYCIN USP (BATCH NO.1949A424003 MFG DT. MAR 2024 RETEST DT. FEB 2027)","address":"1482-1486, TRASAD ROAD,","city":"AHMEDABAD ,GUJARAT","supplier":"CONCORD BIOTECH","supplierCountry":"INDIA","foreign_port":"CHENGDU","customer":"TO ORDER","customerCountry":"CHINA","quantity":"0.09","actualQuantity":"0.085","unit":"KGS","unitRateFc":"300000","totalValueFC":"25061.5","currency":"USD","unitRateINR":24482354.117647059,"date":"21-Mar-2024","totalValueINR":"2081000.1","totalValueInUsd":"25061.5","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"8503878","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"1482-1486, TRASAD ROAD,, AHMEDABAD ,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1716402600,"product":"MITOMYCIN USP-BATCH NO.1949A424003-1949A423008 MFG.DT MAR 2024 - JUL 2023 RETESTDT. FEB 2027-JUN 2026","address":"1482-1486, TRASAD ROAD,","city":"AHMEDABAD ,GUJARAT","supplier":"CONCORD BIOTECH","supplierCountry":"INDIA","foreign_port":"NEWARK, NJ","customer":"TO ORDER","customerCountry":"UNITED STATES","quantity":"0.01","actualQuantity":"0.01","unit":"KGS","unitRateFc":"325000","totalValueFC":"2974.7","currency":"USD","unitRateINR":24795000,"date":"23-May-2024","totalValueINR":"247950","totalValueInUsd":"2974.7","indian_port":"Ahmedabad Air","hs_no":"29420090","bill_no":"1112683","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"1482-1486, TRASAD ROAD,, AHMEDABAD ,GUJARAT","customerAddress":""},{"dataSource":"API Import","activeIngredients":"MITOMYCIN","year":"2021","qtr":"Q1","strtotime":1609957800,"product":"MITOMYCIN IP","address":"304,TOWN CENTRE,ANDHERI KURLA ROAD,ANDHERI (E)","city":"MUMBAI \/ MAHARASHTRA","supplier":"APC PHARMACEUTICALS & CHEMICALS LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"NAPROD LIFE SCIENCES","customerCountry":"INDIA","quantity":"0.60","actualQuantity":"0.6","unit":"KGS","unitRateFc":"275000","totalValueFC":"167962.6","currency":"USD","unitRateINR":"20473750","date":"07-Jan-2021","totalValueINR":"12284250","totalValueInUsd":"167962.6","indian_port":"BOMBAY AIR","hs_no":"29419090","bill_no":"2267773","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"","customerAddress":"304,TOWN CENTRE,ANDHERI KURLA ROAD,ANDHERI (E)"},{"dataSource":"API Import","activeIngredients":"MITOMYCIN","year":"2021","qtr":"Q2","strtotime":1621967400,"product":"77010AO MITOMYCIN NON STERILE -NCV FOR ANALYTICAL TESTS PURPOSE (FOC SAMPLES)","address":"M-34, SAKET\\r\\n\tnull","city":"NEW DELHI","supplier":"TEVA PHARMACEUTICAL INDUSTRIES","supplierCountry":"ITALY","foreign_port":"MILAN - MALPENSA","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"6","unit":"GMS","unitRateFc":"289","totalValueFC":"2149.5","currency":"EUR","unitRateINR":"26241.2","date":"26-May-2021","totalValueINR":"157447.2","totalValueInUsd":"2149.5","indian_port":"BOMBAY AIR","hs_no":"29419090","bill_no":"4087615","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Non-sterile","supplierPort":"MILAN - MALPENSA","supplierAddress":"","customerAddress":"M-34, SAKET\\r\\n\tnull"},{"dataSource":"API Import","activeIngredients":"MITOMYCIN","year":"2021","qtr":"Q2","strtotime":1621967400,"product":"897010H MITOMYCIN -NCV FOR ANALYTICAL TESTS PURPOSE (FOC SAMPLES)","address":"M-34, SAKET\\r\\n\tnull","city":"NEW DELHI","supplier":"TEVA PHARMACEUTICAL INDUSTRIES","supplierCountry":"ITALY","foreign_port":"MILAN - MALPENSA","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.5","unit":"GMS","unitRateFc":"289","totalValueFC":"179.1","currency":"EUR","unitRateINR":"26241.2","date":"26-May-2021","totalValueINR":"13120.6","totalValueInUsd":"179.1","indian_port":"BOMBAY AIR","hs_no":"29419090","bill_no":"4087615","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"MILAN - MALPENSA","supplierAddress":"","customerAddress":"M-34, SAKET\\r\\n\tnull"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1628706600,"product":"MITOMYCIN IP B.NO.1127011N201201 MFG DT 2021.01.14 EXP DT 2023.12","address":"301 CEEJAY HOUSE LEVEL 3 SHIVSAGAR","city":"MUMBAI,MAHARASHTRA","supplier":"ZHEJIANG HISUN PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"ARSHIYA LOGISTICS SERVICES LTD","customerCountry":"INDIA","quantity":"0.25","actualQuantity":"250","unit":"GMS","unitRateFc":"237.6","totalValueFC":"60157.9","currency":"USD","unitRateINR":"17847","date":"12-Aug-2021","totalValueINR":"4461761","totalValueInUsd":"60157.9","indian_port":"ARSHIYA-SEZ\/PANVEL","hs_no":"29419019","bill_no":"1008780","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"N\/A","customerAddress":"301 CEEJAY HOUSE LEVEL 3 SHIVSAGAR"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1638729000,"product":"CHEMICAL : MITOMYCIN USP","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ","city":"AHMEDABAD,GUJARAT","supplier":"ZHEJIANG HISUN PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"N\/A","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.06","actualQuantity":"60","unit":"GMS","unitRateFc":"320","totalValueFC":"19320.6","currency":"USD","unitRateINR":"24288","date":"06-Dec-2021","totalValueINR":"1457280","totalValueInUsd":"19320.6","indian_port":"AHMEDABAD AIR","hs_no":"29419090","bill_no":"6553803","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1646850600,"product":"MITOMYCIN(LICENCE: IL\/BD-011654 RC\/BD-002523)","address":"SCO 162-64 SECTOR 34A,AIR INDIA BU ILDING","city":"CHANDIGARH,CHANDIGARH","supplier":"BIOBETTA LIMITED","supplierCountry":"CHINA","foreign_port":"NA","customer":"HEALTH BIOTECH","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"0.01","unit":"KGS","unitRateFc":"220000","totalValueFC":"2212.4","currency":"USD","unitRateINR":"16863000","date":"10-Mar-2022","totalValueINR":"168630","totalValueInUsd":"2212.4","indian_port":"DELHI AIR","hs_no":"29349990","bill_no":"7804215","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"SCO 162-64 SECTOR 34A,AIR INDIA BU ILDING"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655490600,"product":"MITOMYCIN(QTY: 1X0.35 GMS,PRICE: USD 117.83)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00035","unit":"KGS","unitRateFc":"336657.1","totalValueFC":"121.3","currency":"USD","unitRateINR":"27031257.1","date":"18-Jun-2022","totalValueINR":"9460.94","totalValueInUsd":"121.3","indian_port":"HYDERABAD AIR","hs_no":"29419090","bill_no":"9166190","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655490600,"product":"MITOMYCIN(QTY: 3X0.2 GMS,PRICE: USD 71.21\/EACH)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0006","unit":"KGS","unitRateFc":"356050","totalValueFC":"219.9","currency":"USD","unitRateINR":"28588350","date":"18-Jun-2022","totalValueINR":"17153.01","totalValueInUsd":"219.9","indian_port":"HYDERABAD AIR","hs_no":"29419090","bill_no":"9166190","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655490600,"product":"MITOMYCIN(QTY: 4X50 MG,PRICE: USD 788\/EACH)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0002","unit":"KGS","unitRateFc":"15760000","totalValueFC":"3244","currency":"USD","unitRateINR":"1265419250","date":"18-Jun-2022","totalValueINR":"253083.85","totalValueInUsd":"3244","indian_port":"HYDERABAD AIR","hs_no":"29419090","bill_no":"9166190","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1656268200,"product":"CHEMICAL : MITOMYCIN NON STERILE","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"TEVA API","supplierCountry":"ITALY","foreign_port":"N\/A","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.27","actualQuantity":"270","unit":"GMS","unitRateFc":"1000","totalValueFC":"273234.9","currency":"USD","unitRateINR":"78950","date":"27-Jun-2022","totalValueINR":"21316500","totalValueInUsd":"273234.9","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29419090","bill_no":"1002584","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Non-sterile","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1656268200,"product":"MITOMYCIN NON STERILE - 77010AO - LOT #7010AO00521 (QTY 300GRMS)","address":"564\/A\/22, ROAD NO. 92,JUBILEE HILL S,","city":"HYDERABAD,TELANGANA","supplier":"TEVA API","supplierCountry":"ITALY","foreign_port":"NA","customer":"VIATRIS","customerCountry":"INDIA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"850000","totalValueFC":"258055.2","currency":"USD","unitRateINR":"67107500","date":"27-Jun-2022","totalValueINR":"20132250","totalValueInUsd":"258055.2","indian_port":"BANGALORE AIR","hs_no":"29419090","bill_no":"9301231","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Non-sterile","supplierPort":"NA","supplierAddress":"","customerAddress":"564\/A\/22, ROAD NO. 92,JUBILEE HILL S,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1663698600,"product":"MITOMYCIN USP","address":"","city":"","supplier":"ZHEJIANG HISUN PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"NA","customer":"ALCHEM EXCIPIENTS","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"25","unit":"GMS","unitRateFc":"280","totalValueFC":"7022.6","currency":"USD","unitRateINR":"22512","date":"21-Sep-2022","totalValueINR":"562800","totalValueInUsd":"7022.6","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"2538193","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1668364200,"product":"MITOMYCIN EP\/BP\/IP\/USP\/PH.EUR","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ","city":"AHMEDABAD,GUJARAT","supplier":"ZHEJIANG HISUN PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"NA","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.06","actualQuantity":"55","unit":"GMS","unitRateFc":"300","totalValueFC":"16942.2","currency":"USD","unitRateINR":"25140","date":"14-Nov-2022","totalValueINR":"1382700","totalValueInUsd":"16942.2","indian_port":"AHMEDABAD AIR","hs_no":"29419090","bill_no":"3301669","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1678645800,"product":"MITOMYCIN NON STERILE","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"TEVA API","supplierCountry":"ITALY","foreign_port":"N\/A","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.42","actualQuantity":"420","unit":"GMS","unitRateFc":"1000","totalValueFC":"426381.1","currency":"USD","unitRateINR":"83500","date":"13-Mar-2023","totalValueINR":"35070000","totalValueInUsd":"426381.1","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29419090","bill_no":"1001057","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Non-sterile","supplierPort":"N\/A","supplierAddress":"PIET HEIN BUILDING PIET HEINKADE 10 1019 GM AMSTERDAM THE NETHERLAND NETHERLANDS","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1681065000,"product":"MITOMYCIN USP, ITEM CODE: C1382130 - AS PER INVOICE","address":"PLOT NO.2, MAITHRIVIHAR AMEERPET,","city":"HYDERABAD","supplier":"ZHEJIANG HISUN PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"NA","customer":"EUGIA PHARMA SPECIALITIES ","customerCountry":"INDIA","quantity":"0.32","actualQuantity":"316","unit":"GMS","unitRateFc":"268","totalValueFC":"85614.1","currency":"USD","unitRateINR":"22203.8","date":"10-Apr-2023","totalValueINR":"7016400.8","totalValueInUsd":"85614.1","indian_port":"HYDERABAD AIR","hs_no":"29419090","bill_no":"5452023","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"PLOT NO.2, MAITHRIVIHAR AMEERPET,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1681237800,"product":"MITOMYCIN USP\/PH. EUR.","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ","city":"AHMEDABAD,GUJARAT","supplier":"ZHEJIANG HISUN PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"NA","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.86","actualQuantity":"856","unit":"GMS","unitRateFc":"255","totalValueFC":"220667","currency":"USD","unitRateINR":"21126.8","date":"12-Apr-2023","totalValueINR":"18084498","totalValueInUsd":"220667","indian_port":"AHMEDABAD AIR","hs_no":"29419090","bill_no":"5479126","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1685989800,"product":"MITOMYCIN IP","address":"304,TOWN CENTRE, ANDHERI KURLA ROAD, ANDHERI EAST","city":"MUMBAI","supplier":"APC PHARMACEUTICALS & CHEMICALS LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"NAPROD LIFE SCIENCES","customerCountry":"INDIA","quantity":"0.35","actualQuantity":"0.35","unit":"KGS","unitRateFc":"240000","totalValueFC":"85230.1","currency":"USD","unitRateINR":"20016000.4","date":"06-Jun-2023","totalValueINR":"7005599.972","totalValueInUsd":"85230.1","indian_port":"BOMBAY AIR","hs_no":"29419090","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"304,TOWN CENTRE, ANDHERI KURLA ROAD, ANDHERI EAST"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1688322600,"product":"MITOMYCIN USP (FOR TESTING PURPOSE ONLY)","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"APC PHARMACEUTICALS & CHEMICALS LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"CIPLA","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"5","unit":"GMS","unitRateFc":"200","totalValueFC":"1010.5","currency":"USD","unitRateINR":"16610","date":"03-Jul-2023","totalValueINR":"83050.1","totalValueInUsd":"1010.5","indian_port":"BOMBAY AIR","hs_no":"29419090","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1690914600,"product":"MITOMYCIN","address":"6-3-865\/1\/2, FLAT NO.201,","city":"HYDERABAD, ANDHRA PRADESH","supplier":"ZHEJIANG HISUN PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"GLAND PHARMA LIMITED","customerCountry":"INDIA","quantity":"0.85","actualQuantity":"850","unit":"GMS","unitRateFc":"255","totalValueFC":"217047.5","currency":"USD","unitRateINR":"21152.3","date":"02-Aug-2023","totalValueINR":"17979413","totalValueInUsd":"217047.5","indian_port":"Vizag-EPZ\/SEZ","hs_no":"29419090","bill_no":"1001453","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.46,WAISHA ROAD,JIAOJIANG,TAIZHOU,ZHEJIANG,P.R.CHINASDNF China","customerAddress":"6-3-865\/1\/2, FLAT NO.201,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696444200,"product":"(77010AO) MITOMYCIN NON STERILE","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"TEVA API","supplierCountry":"ITALY","foreign_port":"N\/A","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.93","actualQuantity":"927","unit":"GMS","unitRateFc":"700","totalValueFC":"655298.6","currency":"USD","unitRateINR":"58835","date":"05-Oct-2023","totalValueINR":"54540045","totalValueInUsd":"655298.6","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29419090","bill_no":"1004108","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Non-sterile","supplierPort":"N\/A","supplierAddress":"PIET HEIN BUILDING, PIET HEINKADE 1 07 1019 GM AMSTERDAM THE NEATHERLAN D NETHERLANDS","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1698604200,"product":"MITOMYCIN USP","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"ZHEJIANG HISUN PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1000","unit":"GMS","unitRateFc":"250","totalValueFC":"252915.8","currency":"USD","unitRateINR":"21050","date":"30-Oct-2023","totalValueINR":"21050000","totalValueInUsd":"252915.8","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29419090","bill_no":"1004434","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.46 WAISHA ROAD, JIAOJIANG, TAIZHOU, ZHEJIANG, , CHINA","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1701109800,"product":"MITOMYCIN NON STERILE - 77010AO - 7010AO00223 (QTY 250 GRM)","address":"564\/A\/22, ROAD NO.92","city":"HYDERABAD,ANDHRA PRADESH","supplier":"TEVA API","supplierCountry":"ITALY","foreign_port":"MILAN - MALPENSA","customer":"VIATRIS","customerCountry":"INDIA","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"894200","totalValueFC":"225775.9","currency":"USD","unitRateINR":"75202220","date":"28-Nov-2023","totalValueINR":"18800555","totalValueInUsd":"225775.9","indian_port":"Bangalore Air","hs_no":"29419090","bill_no":"8976085","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Non-sterile","supplierPort":"MILAN - MALPENSA","supplierAddress":"Piet Hein Building, Piet Heinkade 107 1019 GM Amsterdam The Netherlands Netherlands","customerAddress":"564\/A\/22, ROAD NO.92"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705516200,"product":"MITOMYCIN IP","address":"304,TOWN CENTRE,","city":"MUMBAI \/ MAHARASHTRA","supplier":"APC PHARMACEUTICALS & CHEMICALS LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"NAPROD LIFE SCIENCES","customerCountry":"INDIA","quantity":"0.44","actualQuantity":"0.441","unit":"KGS","unitRateFc":"225000","totalValueFC":"100584","currency":"USD","unitRateINR":"18956250","date":"18-Jan-2024","totalValueINR":"8359706.25","totalValueInUsd":"100584","indian_port":"Bombay Air","hs_no":"29419090","bill_no":"9712285","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"UNIT 1003, BANK OF EAST ASIA HARBOUR, VIEW CENTRE NO 56, GLOUCESTER ROAD, WAN CHAI HONG KONG","customerAddress":"304,TOWN CENTRE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711650600,"product":"MITOMYCIN USP","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"ZHEJIANG HISUN PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1000","unit":"GMS","unitRateFc":"250","totalValueFC":"252903","currency":"USD","unitRateINR":"21000","date":"29-Mar-2024","totalValueINR":"21000000","totalValueInUsd":"252903","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29419090","bill_no":"1001201","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.46 WAISHA ROAD, JIAOJIANG, TAIZHOU, ZHEJIANG, , CHINA","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713897000,"product":"MITOMYCIN IP","address":"304,TOWN CENTRE,","city":"MUMBAI \/ MAHARASHTRA","supplier":"APC PHARMACEUTICALS & CHEMICALS LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"NAPROD LIFE SCIENCES","customerCountry":"INDIA","quantity":"0.25","actualQuantity":"0.249","unit":"KGS","unitRateFc":"225000","totalValueFC":"56623.9","currency":"USD","unitRateINR":"18990000","date":"24-Apr-2024","totalValueINR":"4728510","totalValueInUsd":"56623.9","indian_port":"Bombay Air","hs_no":"29419090","bill_no":"3175471","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"UNIT 1003, BANK OF EAST ASIA HARBOUR VIEW CENTRE, NO. 56, GLOUCESTER ROAD, WAN CHAI HONG KONG","customerAddress":"304,TOWN CENTRE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715797800,"product":"(77010AO) MITOMYCIN NON STERILE","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"TEVA API B. V","supplierCountry":"ITALY","foreign_port":"N\/A","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.35","actualQuantity":"350","unit":"GMS","unitRateFc":"700","totalValueFC":"247927","currency":"USD","unitRateINR":"59045","date":"16-May-2024","totalValueINR":"20665750","totalValueInUsd":"247927","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29419090","bill_no":"1001782","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Non-sterile","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720981800,"product":"MITOMYCIN USP (QTY-250 GMS) (CAS NO:50-07-7)","address":"PLOT NO.2, MAITHRIVIHAR,","city":"HYDERABAD, AP.","supplier":"ZHEJIANG HISUN PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"EUGIA PHARMA SPECIALITIES ","customerCountry":"INDIA","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"252000","totalValueFC":"63647.3","currency":"USD","unitRateINR":"21281400","date":"15-Jul-2024","totalValueINR":"5320350","totalValueInUsd":"63647.3","indian_port":"Hyderabad Air","hs_no":"29419090","bill_no":"4508639","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.46 WAISHA ROAD JIAOJIANG TAIZHOUZHEJIANG P.R CHINASDNF China","customerAddress":"PLOT NO.2, MAITHRIVIHAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727634600,"product":"(77010AO) MITOMYCIN NON STERILE","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"TEVA API","supplierCountry":"ITALY","foreign_port":"MILANO","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.60","actualQuantity":"600","unit":"GMS","unitRateFc":"500","totalValueFC":"302859.5","currency":"USD","unitRateINR":"42300","date":"30-Sep-2024","totalValueINR":"25380000","totalValueInUsd":"302859.5","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29419090","bill_no":"5871224","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Non-sterile","supplierPort":"MILANO","supplierAddress":"Piet Hein Building, Piet Heinkade 107 1019 GM Amsterdam Netherlands SDNF Netherlands","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"}]
07-Jan-2021
30-Sep-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Europe

read-more
read-more

01

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

Mitomycin

Brand Name : Mitomycin C

Dosage Form : Mitomycin 10Mg 1 Unit Parenteral Use

Dosage Strength : 1 vial EV 10 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

02

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

Mitomycin

Brand Name : Mitomycin C

Dosage Form : Mitomycin 40Mg 1 Unit Parenteral Use

Dosage Strength : 1 vial EV 40 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

medac GmbH,

Germany
Antibody Engineering
Not Confirmed
arrow

medac GmbH,

Germany
arrow
Antibody Engineering
Not Confirmed

mitomycin

Brand Name : Mitomycin medac

Dosage Form : PULVER OCH VÄTSKA TILL INTRAVESIKAL LÖSNING

Dosage Strength : 20 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

medac GmbH,

Germany
Antibody Engineering
Not Confirmed
arrow

medac GmbH,

Germany
arrow
Antibody Engineering
Not Confirmed

mitomycin

Brand Name : Mitomycin medac

Dosage Form : PULVER OCH VÄTSKA TILL INTRAVESIKAL LÖSNING

Dosage Strength : 40 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

05

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

mitomycin

Brand Name : Mitomycin Mylan

Dosage Form : PULVER TILL INJEKTIONS-/INFUSIONSVÄTSKA

Dosage Strength : 40 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

06

medac Gesellschaft für

Country
Antibody Engineering
Not Confirmed
arrow

medac Gesellschaft für

Country
arrow
Antibody Engineering
Not Confirmed

mitomycin

Brand Name : Mitomycin

Dosage Form : PULVER OCH VÄTSKA TILL INTRAVESIKAL

Dosage Strength : 1 MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

07

medac Gesellschaft für

Country
Antibody Engineering
Not Confirmed
arrow

medac Gesellschaft für

Country
arrow
Antibody Engineering
Not Confirmed

mitomycin

Brand Name : Mitomycin

Dosage Form : PULVER TILL INFUSIONSVÄTSKA, LÖSNING

Dosage Strength : --

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

08

Speciality European Pharma Ltd,

Country
Antibody Engineering
Not Confirmed
arrow

Speciality European Pharma Ltd,

Country
arrow
Antibody Engineering
Not Confirmed

mitomycin

Brand Name : Mitomycin SEP

Dosage Form : PULVER TILL INJEKTIONS-/INFUSIONSVÄTSKA

Dosage Strength : 20 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

09

Speciality European Pharma Ltd,

Country
Antibody Engineering
Not Confirmed
arrow

Speciality European Pharma Ltd,

Country
arrow
Antibody Engineering
Not Confirmed

mitomycin

Brand Name : Mitomycin SEP

Dosage Form : PULVER OCH VÄTSKA TILL INTRAVESIKAL

Dosage Strength : 20 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

10

Medac - Gesellschaft für klinische Spez...

Country
Antibody Engineering
Not Confirmed
arrow

Medac - Gesellschaft für klinische Spez...

Country
arrow
Antibody Engineering
Not Confirmed

Mitomycin

Brand Name : Mitomycin medac

Dosage Form : Powder and liquid to intravesikaloppløsning

Dosage Strength : 40 mg

Packaging : Set

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Taste Masking

read-more
read-more

Direct Compression

read-more
read-more

Co-Processed Excipients

read-more
read-more

Parenteral

read-more
read-more

Granulation

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

API Stability Enhancers

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty